Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to...
Search for Articles
Mar 28, 2022
Mar 25, 2022
Renovacor Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Feb 28, 2022
Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Feb 14, 2022
Broadview Ventures 2021 Annual Report
We are pleased to report another robust year of activities in 2021, with several new...
Feb 9, 2022
HAYA Therapeutics Establishes U.S. Location
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics, SA, a company developing precision medicines that target...
Feb 4, 2022
CroíValve Raises an €8M Series A Round to Support a Feasibility Clinical Study Expands the Board of Directors and Leadership Team
Dublin, Ireland, 4 February 2022 – CroíValve, a Dublin based medical device company developing a...